This independent lab test from Janoshik Labs confirms Tirzepatide 30mg from Skye Peptides at 99.953% purity. The analysis was conducted on March 24, 2024, with tested quantity of 33.69mg. Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. The exceptional purity level of 99.953% indicates minimal contamination and pharmaceutical-grade synthesis quality. The tested quantity of 33.69mg exceeds the stated label claim of 30mg, demonstrating product integrity. The full certificate of analysis is available for verification on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.